Stay updated on Durvalumab Combinations in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combinations in NSCLC Clinical Trial page.

Latest updates to the Durvalumab Combinations in NSCLC Clinical Trial page
- CheckyesterdayChange DetectedThe website footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check8 days agoChange DetectedThe ClinicalTrials.gov page footer now identifies the site as revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedRevision: v3.7.0 added to the page history, replacing v3.6.6. This appears to be a software update to the site UI and layout rather than a change to study details.SummaryDifference0.1%

- Check51 days agoChange DetectedThe revision history now shows the latest revision as v3.6.6, replacing the previous v3.6.5 entry.SummaryDifference0.1%

- Check71 days agoChange DetectedA new revision (v3.6.5) has been added to the study's record history, replacing the previous revision (v3.6.4). This reflects an update to the page's revision metadata without impacting the study data or status.SummaryDifference0.1%

- Check86 days agoChange DetectedThe history list now includes a new revision entry, v3.6.4, replacing the previous v3.6.3. This update reflects revised revision metadata for the study record.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Combinations in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combinations in NSCLC Clinical Trial page.